STAT Plus: Gilead’s twice-yearly antiviral protected women from HIV infection in large trial
Gilead Sciences
News roundup for Gilead Sciences, Inc., a California-based biopharmaceutical company. It’s most known for researching and developing antiviral drugs used to treat HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19.
Latest
STAT Plus: Gilead gets a boost from California court in a case over slow-walking an HIV drug
Study: Gilead antiviral drug shows promise as a treatment for Ebola Sudan
Listen: Pharma goes to Washington, Alnylam’s future, & Gilead’s dealmaking
Listen: The plight of the VC, Gilead’s latest setback, & more M&A
STAT Plus: Gilead’s Trodelvy fails in lung cancer and raises new questions on antibody drug conjugate drugs
STAT Plus: No pain data yet from Vertex, and sky high deal expectations at JPM 2024
STAT Plus: Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high
All Coverage
advertisement
